OBJECTIVE: Protein-energy wasting and inflammation are common and associated with an increased risk of mortality in hemodialysis (HD) patients. We examined the extent to which they mediate the associations of each other with death in this population. STUDY DESIGN: Retrospective analysis of the Hemodialysis (HEMO) Study data. SETTING: Prevalent HD patients. PARTICIPANTS: One-thousand HEMO study participants with data available on C-reactive protein (CRP), body mass index (BMI), and serum creatinine. INTERVENTION: None. MAIN OUTCOME MEASURE: The associations of CRP, BMI, and serum creatinine with time to all-cause mortality separately and together in multivariate Cox models. RESULTS: In 1,437 patient-years of follow-up, there were 265 (26.5%) all-cause deaths. Compared with the lowest CRP quartile, the highest quartile was associated with a hazard ratio (HR) of 2.02 (95% confidence interval [CI], 1.31-3.10) for all-cause mortality. This association of highest CRP quartile with mortality was not attenuated with further adjustment for BMI and serum creatinine (HR, 2.13; 95% CI, 1.38-3.30). When serum albumin was added to the model, the hazard of death associated with highest CRP quartile was modestly attenuated (HR, 1.88; 95% CI, 1.21-2.92). In contrast, both BMI (for each kg/m2 increase; HR, 0.94; 95% CI, 0.91-0.96 for all-cause mortality) and serum creatinine (for each mg/dL increase; HR, 0.85; 95% CI, 0.79-0.90 for all-cause mortality) had strong, independent protective effects. Further adjustment with CRP had a negligible effect on these associations. CONCLUSION: The associations of markers of nutrition and inflammation with mortality are largely independent of each other in HD patients.
OBJECTIVE: Protein-energy wasting and inflammation are common and associated with an increased risk of mortality in hemodialysis (HD) patients. We examined the extent to which they mediate the associations of each other with death in this population. STUDY DESIGN: Retrospective analysis of the Hemodialysis (HEMO) Study data. SETTING: Prevalent HDpatients. PARTICIPANTS: One-thousand HEMO study participants with data available on C-reactive protein (CRP), body mass index (BMI), and serum creatinine. INTERVENTION: None. MAIN OUTCOME MEASURE: The associations of CRP, BMI, and serum creatinine with time to all-cause mortality separately and together in multivariate Cox models. RESULTS: In 1,437 patient-years of follow-up, there were 265 (26.5%) all-cause deaths. Compared with the lowest CRP quartile, the highest quartile was associated with a hazard ratio (HR) of 2.02 (95% confidence interval [CI], 1.31-3.10) for all-cause mortality. This association of highest CRP quartile with mortality was not attenuated with further adjustment for BMI and serum creatinine (HR, 2.13; 95% CI, 1.38-3.30). When serum albumin was added to the model, the hazard of death associated with highest CRP quartile was modestly attenuated (HR, 1.88; 95% CI, 1.21-2.92). In contrast, both BMI (for each kg/m2 increase; HR, 0.94; 95% CI, 0.91-0.96 for all-cause mortality) and serum creatinine (for each mg/dL increase; HR, 0.85; 95% CI, 0.79-0.90 for all-cause mortality) had strong, independent protective effects. Further adjustment with CRP had a negligible effect on these associations. CONCLUSION: The associations of markers of nutrition and inflammation with mortality are largely independent of each other in HDpatients.
Authors: Trinh B Pifer; Keith P McCullough; Friedrich K Port; David A Goodkin; Bradley J Maroni; Philip J Held; Eric W Young Journal: Kidney Int Date: 2002-12 Impact factor: 10.612
Authors: Jessica L Clarke; Jeffrey L Anderson; John F Carlquist; Richard F Roberts; Benjamin D Horne; Tami L Bair; Matthew J Kolek; Chrissa P Mower; Ashle M Crane; William L Roberts; Joseph B Muhlestein Journal: Am J Cardiol Date: 2005-01-01 Impact factor: 2.778
Authors: Kamyar Kalantar-Zadeh; Kevin C Abbott; Abdulla K Salahudeen; Ryan D Kilpatrick; Tamara B Horwich Journal: Am J Clin Nutr Date: 2005-03 Impact factor: 7.045
Authors: George A Kaysen; Tom Greene; John T Daugirdas; Paul L Kimmel; Gerald W Schulman; Robert D Toto; Nathan W Levin; Guofen Yan Journal: Am J Kidney Dis Date: 2003-12 Impact factor: 8.860
Authors: Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen Kaufman; Julia Lewis; Michael Rocco; Robert Toto; David Windus; Daniel Ornt; Andrew S Levey Journal: Kidney Int Date: 2004-06 Impact factor: 10.612
Authors: Lara B Pupim; Paul J Flakoll; John R Brouillette; Deanna K Levenhagen; Raymond M Hakim; T Alp Ikizler Journal: J Clin Invest Date: 2002-08 Impact factor: 14.808
Authors: Shani Shastri; Navdeep Tangri; Hocine Tighiouart; Gerald J Beck; Panagiotis Vlagopoulos; Daniel Ornt; Garabed Eknoyan; John W Kusek; Charles Herzog; Alfred K Cheung; Mark J Sarnak Journal: Clin J Am Soc Nephrol Date: 2011-11-10 Impact factor: 8.237
Authors: Franciele D Vannini; Aline A Antunes; Jacqueline C T Caramori; Luis C Martin; Pasqual Barretti Journal: Int Urol Nephrol Date: 2009-12 Impact factor: 2.370
Authors: Wilfred Druml; Barbara Metnitz; Eva Schaden; Peter Bauer; Philipp G H Metnitz Journal: Intensive Care Med Date: 2010-03-16 Impact factor: 17.440
Authors: Manish P Ponda; Irina Barash; Jonathan E Feig; Edward A Fisher; Edward Y Skolnik Journal: Atherosclerosis Date: 2009-10-29 Impact factor: 5.162
Authors: Cindy X Huang; Hocine Tighiouart; Srinivasan Beddhu; Alfred K Cheung; Johanna T Dwyer; Garabed Eknoyan; Gerald J Beck; Andrew S Levey; Mark J Sarnak Journal: Kidney Int Date: 2010-01-13 Impact factor: 10.612
Authors: Dorota Brodowska-Kania; Aleksandra Rymarz; Krzysztof Gibin Ski; Julia Kiełczewska; Jerzy Smoszna; Marek Saracyn; Katarzyna Szamotulska; Stanisław Niemczyk Journal: Nagoya J Med Sci Date: 2015-11 Impact factor: 1.131